Imatron wants smaller stake in lossmaking HeartScan
This article was originally published in Clinica
Executive Summary
Imatron, which manufactures and markets ultrafast CT scanners capable of making tomograms of moving organs such as the heart, wants to reduce its stake in HeartScan Imaging, CEO S Lewis Meyer said. In 1996, the company posted a net loss of $10.5 million including $4.6 million in losses associated with HeartScan.